Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Tunlametinib
Trade Name
Synonyms HL-085|HL085|HL 085
Drug Descriptions

Tunlametinib (HL-085) is a MEK inhibitor that may inhibit proliferation of tumor cells (Cancer Res 2019;79(13 Suppl):Abstract nr 4753).

DrugClasses MEK inhibitor (Pan) 24
CAS Registry Number 1801756-06-8
NCIT ID C173437


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Adagrasib + Tunlametinib Adagrasib Tunlametinib 0 0
Docetaxel + Tunlametinib Docetaxel Tunlametinib 0 0
OKI-005 + Tunlametinib OKI-005 Tunlametinib 0 0
SHP099 + Tunlametinib SHP099 Tunlametinib 0 0
Sotorasib + Tunlametinib Sotorasib Tunlametinib 0 0
Tunlametinib Tunlametinib 12 2
Tunlametinib + Vemurafenib Tunlametinib Vemurafenib 4 0

Additional content available in CKB BOOST